Combined hepatocellular and cholangiocarcinoma (biphenotypic) tumors: Imaging features and diagnostic accuracy of contrast-enhanced CT and MRI

American Journal of Roentgenology

Volumn 201, Issue 2, 2013, Pages 332-339

  Fowler, Kathryn J ^a   Sheybani, Arman ^b   Parke III, Rex A ^c   Doherty, Sean ^a   Brunt, Elizabeth M ^d   Chapman, William C ^d   Menias, Christine O ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c KAISER PERMANENTE MEDICAL CENTER   (United States)

^d WASHINGTON UNIVERSITY   (United States)

Author keywords

Biphenotypic; Cholangiocarcinoma; CT; Hepatocellular carcinoma; MRI

Indexed keywords

GADOBENATE DIMEGLUMINE; GADOXETIC ACID; TUMOR MARKER;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER RISK; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC IMAGING; FEMALE; HEPATITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RADIOLOGIST; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; CONTRAST MEDIA; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; TUMOR MARKERS, BIOLOGICAL;

EID: 84883732267     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.12.9488     Document Type: Article

References (31)

1. Allen RA, Lisa JR. Combined liver cell and bile duct carcinoma. Am J Pathol 1949; 25:647-655
2. Theise N, Nakashima O, Park YN, Nakanuma Y. Combined hepatocellular- cholangiocarcinoma: WHO classification of tumours of the digestive system. Lyon, France: IARC, 2010:225-227
3. Jarnagin WR, Weber S, Tickoo SK, et al. Combined hepatocellular and cholangiocarcinoma: demographic, clinical and prognostic factors. Cancer 2002; 94:2040-2046
4. Yano Y, Yamamoto J, Kosuge T, et al. Combined hepatocellular and cholangiocarcinoma: a clinicopathologic study of 26 resected cases. Jpn J Clin Oncol 2003; 33:283-287
5. Zhang F, Chen XP, Zhang W, et al. Combined hepatocellular cholangiocarcinoma originating from hepatic progenitor cells: immunohistochemical and double-fluorescence immunostaining evidence. Histopathology 2008; 52:224-232
6. Itoyama M, Hata M, Yamanegi K, et al. Expression of both hepatocellular carcinoma and cholangiocarcinoma phenotypes in hepatocellular carcinoma and cholangiocarcinoma components in combined hepatocellular and cholangiocarcinoma. Med Mol Morphol 2012; 45:7-13
7. Woo HG, Lee JH, Yoon JH, et al. Identification of a cholangiocarcinoma- like gene expression trait in hepatocellular carcinoma. Cancer Res 2010; 70:3034-3041
8. Fujii H, Zhu XG, Matsumoto T, et al. Genetic classification of combined hepatocellular-cholangiocarcinoma. Hum Pathol 2000; 31:1011-1017
9. Yano H, Iemura A, Haramaki M, et al. A human combined hepatocellular and cholangiocarcinoma cell line (KMCH-2) that shows the features of hepatocellular carcinoma or cholangiocarcinoma under different growth conditions. J Hepatol 1996; 24:413-422
10. Kim H, Park C, Han KH, et al. Primary liver carcinoma of intermediate (hepatocyte-cholangiocyte) phenotype. J Hepatol 2004; 40:298-304
11. Tanaka S, Yamamoto T, Tanaka H, et al. Potentiality of combined hepatocellular and intrahepatic cholangiocellular carcinoma originating from a hepatic precursor cell: immunohistochemical evidence. Hepatol Res 2005; 32:52-57
12. Theise ND, Yao JL, Harada K, et al. Hepatic 'stem cell' malignancies in adults: four cases. Histopathology 2003; 43:263-271
13. Seok JY, Na DC, Woo HG, et al. A fibrous stromal component in hepatocellular carcinoma reveals a cholangiocarcinoma-like gene expression trait and epithelial-mesenchymal transition. Hepatology 2012; 55:1776-1786
14. Yin X, Zhang BH, Qiu SJ, et al. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis. Ann Surg Oncol 2012; 19:2869-2876
15. Koh KC, Lee H, Choi M, et al. Clinicopathologic features and prognosis of combined hepatocellular cholangiocarcinoma. Am J Surg 2005; 189:120-125
16. Liu CL, Fan ST, Lo CM, et al. Hepatic resection for combined hepatocellular and cholangiocarcinoma. Arch Surg 2003; 138:86-90
17. Ng IO, Shek TW, Nicholls J, Ma LT. Combined hepatocellular- cholangiocarcinoma: a clinicopathologic study. J Gastroenterol Hepatol 1998; 13:34-40
18. Chantajitr S, Wilasrusmee C, Lertsitichai P, Phromsopha N. Combined hepatocellular and cholangiocarcinoma: clinical features and prognostic study in a Thai population. J Hepatobiliary Pancreat Surg 2006; 13:537-542
19. Taguchi J, Nakashima O, Tanaka M, Hisaka T, Takazawa T, Kojiro M. A clinicopathological study on combined hepatocellular and cholangiocarcinoma. J Gastroenterol Hepatol 1996; 11:758-764
20. Kassahun WT, Hauss J. Management of combined hepatocellular and cholangiocarcinoma. Int J Clin Pract 2008; 62:1271-1278
21. Mathews J, Chapman WC, Vachharajani N, Tan B, Brunt EM. Primary liver carcinoma with biphenotypic expression: 23 cases of combined HCCCCa. (abstr) Proceedings of the United States and Canadian Academy of Pathology annual meeting. Baltimore, MD: United States and Canadian Academy of Pathology
22. Wachtel MS, Zhang Y, Xu T, Chiriva-Internati M, Frezza E. Combined hepatocellular cholangiocarcinomas; analysis of a large database. Clin Med Pathol 2008; 1:43-47
23. Lee JH, Chung G, Yu S, et al. Long-term prognosis of combined hepatocellular and cholangiocarcinoma after curative resection comparison with hepatocellular carcinoma and cholangiocarcinoma. J Clin Gastroenterol 2011; 45:69-75
24. Yu XH, Xu LB, Zeng H, Zhang R, Want J, Liu C. Clinicopathological analysis of 14 patients with combined hepatocellular carcinoma and cholangiocarcinoma. Hepatobiliary Pancreat Dis Int 2011; 10:620-625
25. Zuo HQ, Yan LN, Zeng Y, et al. Clinicopathological characteristics of 15 patients with combined hepatocellular and cholangiocarcinoma. Hepatobiliary Pancreat Dis Int 2007; 6:161-165
26. Lee WS, Lee KW, Heo JS, et al. Comparison of combined hepatocellular and cholangiocarcinoma with hepatocellular and intrahepatic cholangiocarcinoma. Surg Today 2006; 36:892-897
27. Tang D, Nagano H, Nakamura M, et al. Clinical and pathological features of Allen's type C classification of resected combined hepatocellular carcinoma and cholangiocarcinoma: a comparative study with hepatocellular carcinoma and cholangiocellular carcinoma. J Gastrointest Surg 2006; 10:987-998
28. Sanada Y, Shiozaki S, Aoki H, Takakura N, Yoshida K, Yamaguchi Y. A clinical study of 11 cases of combined hepatocellular-cholangiocarcinoma: assessment of enhancement patterns on dynamic computed tomography before resection. Hepatol Res 2005; 32:185-195
29. Aoki K, Takayasu K, Kawano T, et al. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features and computed tomography findings. Hepatology 1993; 18:1090-1095
30. Takada K, Horita S, Meguro T, et al. A case of cholangiocellular carcinoma complicated with intratumoral hemorrhagic necrosis [in Japanese]. Nihon Shokakibyo Gakkai Zasshi 2004; 101:616-621
31. Ebied O, Federle MP, Blachar A, et al. Hepatocellular- cholangiocarcinoma: helical computed tomography findings in 30 patients. J Comput Assist Tomogr 2003; 27:117-124